Apogenix GmbH

The biopharmaceutical company Apogenix, located in Heidelberg, Germany, develops innovative drug candidates which exert their therapeutic effect by modulating the programmed cell death (apoptosis). The therapeutic focus lies on acute cerebro- and cardiovascular diseases (e.g. myocardial infarction) where apoptosis is abnormally increased, and on cancer diseases where apoptosis is abnormally decreased.Apogenix was founded as a spin-out of the German Cancer Research Center (Heidelberg, Germany) by Prof. Peter Krammer and Dr. Henning Walczak in 2000. The company started its operative business in May 2002 as Apogenix Biotechnology AG. Until the end of 2004, therapeutic efficacy of an apoptosis-inhibitor was shown in a variety of animal models (e.g. myocardial infarction, graft-versus-host-disease, stroke). In the context of a financial and organizational restructuring of the company and with the support of private investors, the essential assets were transferred to the newly founded Apogenix GmbH.
Today´s management board members are Dr. Thomas Höger and Dr. Harald Fricke, both having extensive industry experience. Apogenix GmbH is funded by the family of Dietmar Hopp, one of the SAP founders. The family has committed EUR 15m for the (pre)clinical development of the above mentioned apoptosis inhibitor and further drug candidates. Currently, Apogenix occupies about 740m² laboratory and office space in the Technology Park Heidelberg.

Contact Details: Im Neuenheimer Feld 584 Heidelberg 69120 Germany Tel: 49-(0)6221-58608-0 Fax: 49-(0)6221-58608-10 Email: contact@apogenix.com WWW: www.apogenix.com/

BioNews Results for Apogenix GmbH:
Apogenix Receives Orphan Drug Designation for APG101 in the US and Positive Opinion on Orphan Product Designat	Pharma Live:  Nov 18 2009 1:12AM Matching: apogenix gmbh
Medical News: Apogenix Receives Orphan Drug Designation For APG101 In The US And Positive Opinion On Orphan Product Designation In Europe	BioFind:  Nov 16 2009 3:53PM Matching: apogenix gmbh
Apogenix Receives Orphan Drug Designation For APG101 In The US And Positive Opinion On Orphan Product Designat	MediLexicon:  Nov 16 2009 7:47PM Matching: apogenix gmbh
Apogenix Receives Orphan Drug Designation For APG101 In The US And Positive Opinion On Orphan Product Designat	Medical News Today:  Nov 16 2009 4:40PM Matching: apogenix gmbh
Apogenix Significantly Strengthens IP Protection for its Clinical Lead Compound APG101	Pharma Live:  Oct 28 2009 1:56AM Matching: apogenix gmbh
Promote your company here: BioNewsCast - Press Release Distribution	→View more Apogenix GmbH news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 451 times since April 2007, the link to the organisation's website has been followed 76 times

Recent Search Terms used to find this page: harald fricke apogenix | harald fricke apogenix | Apogenix | apogenix biotechnology ag | apogenix biotechnology germany | Apogenix | apogenix biotechnology | apogenix germany | apogenix | .

Search for more companies in Heidelberg

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Apogenix GmbH